1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Vepugratinib: new trials by email Literature Review of Vepugratinib trials Research Report on Vepugratinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Vepugratinib, Placebo, EV - Carcinoma, Transitional Cell, Urinary Bladder Neoplasms | Phase 3 | Recruiting | Eli Lilly and Company | 450 | 2025-12-12 | 2026-10-07 |
Carcinoma, Transitional Cell (1) · Neoplasm Metastasis (1) · Urinary Bladder Neoplasms (1)
Australia (1) · Brazil (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1)
2025 (1)